Nicardipine Hydrochloride Injection
Product Images NDC 65145-197

This text provides information about a medication called Nicardipine Hydrochloride in 0.9% Sodium Chloride Injection. It is for intravenous infusion and contains 20 mg in 200 mL solution. The dosage and administration details are available in the prescribing information. The medication should be stored at temperatures between 20°C to 25°C and protected from light. It is manufactured in India and distributed by Caplin Steriles USA Inc. Discard unused portions and do not use if the solution is not clear. It is also advised not to add any additional medication or use in series connections.*

This description is for a medication labeled as Nicardipine Hydrochloride in 0.9% Sodium Chloride Injection solution for intravenous infusion. The solution comes in a 200 mL single-dose container and each mL contains 0.1 mg of Nicardipine Hydrochloride. It is advised to use the solution immediately after removing it from the overwrap. The product should be stored between 20°C to 25°C and protected from light. The dosage information and administration details can be found in the prescribing information provided. Additionally, the solution is sterile, nonpyrogenic, and caution should be taken to check for leaks and not add supplemental medication. The product is distributed by Caplin Steriles USA Inc. and is manufactured in India.*

This is a medication packaging label for Nicardipine Hydrochloride in 0.9% Sodium Chloride Injection used for intravenous infusion. It contains 40 mg in 200 mL solution with a concentration of 0.2 mg/mL. The label provides information on dosage, administration, cautions, storage instructions, and manufacturing details. It is a sterile, nonpyrogenic solution made in India and distributed by Caplin Steriles USA Inc. Remember to check for leaks, clarity of the solution, and avoid adding other medications.*

This text appears to be a detailed description of a pharmaceutical product containing Nicardipine Hydrochloride in Sodium Chloride Injection, intended for intravenous infusion use. The product is provided in single-dose containers with a concentration of 0.2 mg/mL. The text also includes instructions for use, such as immediate use after removal from overwrap, as well as storage conditions and cautions. Additionally, the text mentions the manufacturer, Caplin Steriles, and provides information on dosage and administration.*